FDA advisory panel recommends FluMist approval for young children (CIDRAP)
May 17, 2007 (CIDRAP News) A US Food and Drug Administration (FDA) advisory panel unanimously agreed Wednesday that FluMist, a nasal spray vaccine against seasonal flu, is safe and effective in children 2 years of age and older.

Elan Corporation Selects Amadeus' eQCM Software for the Management of Their Compliance Worldwide (ThomasNet)
Quebec City, April 19th, 2007 - Amadeus International Inc. (TSX-V: Aii), a pioneer and leader in advanced compliance process control solutions, announced today that Elan Corporation plc, a neuroscience-based biotechnology company, customer of Amadeus since 2005, has entered into extended contractual arrangements to further deploy the eQCM software suite throughout their locations worldwide. ...